Both in Pharmaceuticals
Alzamend Neuro vs Longeveron
Over the past year ALZN returned −22.9% and LGVN returned −64.7%; their daily moves had a correlation of 0.06.
ALZN −22.9% LGVN −64.7%Growth of $1, one year, split-adjusted
| Metric | ALZN | LGVN |
|---|---|---|
| Price | $1.82 | $2.72 |
| Market cap | $8.8M | $8.7M |
| Today | +5.20% | +3.42% |
| 1 month | +9.6% | −59.5% |
| 6 months | +71.7% | −70.8% |
| Year to date | 0.0% | −46.2% |
| 1 year | −24.5% | −66.0% |
| Revenue growth (YoY) | — | −9.2% |
| Gross margin | — | 63.4% |
| Net margin | — | −2116.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.3× |
| Net cash | $7.6M | $10.1M |
| Dividend yield | — | — |
| Volatility (60d) | 49.7% | 706.7% |
| Short % of float | 3.3% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).